Back to the directory
Hepatx
Replacing organ transplant with an infusion
- Founded
- 2015
- Status
- Active
- Stage
- Early
- Team size
- 4
- Location
- San Francisco, CA, USA; Palo Alto
- Category
- Biotech & Drug Discovery
- Sector
- Therapeutics
About Hepatx
Our vision is to provide regenerative medicine treatments that free patients from chronic liver disease and help usher in an era where diseased and damaged tissues can be repaired.
Biotech
Federal research funding
4 NIH awards totalling $699,755, FY2017 to FY2026.
- Development of a proteomic assay for monitoring transplanted cells and tissues
- Development of a process to improve mesenchymal stromal cell banking at therapeutically relevant scale using t
- Development of regenerative medicine therapies for liver failure
Source: NIH RePORTER.
Company data compiled and maintained by Healthcare Discovery.
